Apply for Funding

CPRIT offers several funding opportunities for promising cancer research, product development, and prevention programs. All funding opportunities are announced through formal Requests for Applications (RFAs) and applications must be submitted through the online application receipt system.

Learn more about the grants process.

  Colorectal Cancer Screening Coordinating Center

Program Prevention
RFA Status Open
Description

CPRIT seeks to support 1 Colorectal Cancer Screening Coordinating Center to establish and oversee a collaborative network of regional CPRIT-funded colorectal cancer screening projects, patients, communities, clinicians, and health care professionals. The Center will build the infrastructure necessary for a coordinated statewide evidence-based colorectal cancer screening initiative among all populations and geographic areas of Texas. The Center will serve as a hub of expertise and resources, forge innovative partnerships, catalyze interactions, and enable resource and data sharing among multiple stakeholders across the state to reduce the colorectal cancer burden in the state.

Award: Maximum of $3 million; Maximum duration of 5 years

NOTE: CPRIT plans to make 1 award to a single applicant in response to this RFA.

Review Cycle Fiscal Year 2023 - Cycle 2
RFA Release November 17, 2022
Application Receipt December 15, 2022 - February 23, 2023
Application Review March 2023 - July 2023
Award Notification August 2023

 Dissemination of CPRIT-Funded Cancer Control Interventions

Program Prevention
RFA Status Open
Description

This award mechanism seeks to fund projects that will facilitate the dissemination and implementation of successful CPRIT-funded, evidence-based cancer prevention and control interventions across Texas. The proposed project should be able to develop one or more "products" based on the results of the CPRIT-funded intervention. The proposed project should also identify and assist others to prepare to implement the intervention and/or prepare for grant funding. 

Award: Maximum of $450,000; Maximum duration of 36 months. 

Review Cycle Fiscal Year 2023 - Cycle 2
RFA Release November 17, 2022
Application Receipt December 15, 2022 - February 23, 2023
Application Review March 2023 - July 2023
Award Notification August 2023

Primary Prevention of Cancer

Program Prevention
RFA Status Open
Description

This award mechanism focuses on increasing implementation of evidence-based strategies to ensure that all Texans benefit from the cancer prevention knowledge that we currently have. CPRIT seeks to fund multilevel interventions to reduce cancer risk, disease burden, and cancer disparities. Modifiable risk behaviors include tobacco use, obesity, physical inactivity, unhealthy eating, alcohol use, sun exposure, HPV vaccination, Hepatitis B vaccination, and environmental/ occupational cancer exposures. Applications should also assess and address social determinants that contribute to cancer burden and disparities (e.g., cultural factors, unmet needs, access barriers). Interventions and communications should be structured to address the unique circumstances of the population to be served.

Award: Maximum of $M for new projects and $2.5M for expansion projects; maximum duration of 60 months


Review Cycle Fiscal Year 2023 - Cycle 2
RFA Release November 17, 2022
Application Receipt December 15, 2022 - February 23, 2023
Application Review March 2023 - July 2023
Award Notification August 2023

Cancer Screening and Early Detection

Program Prevention
RFA Status Open
Description

This award mechanism seeks to support the delivery of evidence-based clinical services to screen for cancer and pre-cancer in underserved populations who do not have adequate access to cancer early detection interventions and health care, bringing together networks of public health and community partners to carry out programs tailored for their communities. Projects should identify cancers that cause the most burden in the community, have nationally recommended screening methods, and use evidence-based methods to screen for these cancers.

Award: Maximum of $1.5M for new projects and $2.5M for expansion projects; maximum duration of 60 months

Review Cycle Fiscal Year 2023 - Cycle 2
RFA Release November 17, 2022
Application Receipt December 15, 2022 - February 23, 2023
Application Review March 2023 - July 2023
Award Notification August 2023

SEED Awards

Revised: 10/11/2022

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support company formation, as well as early research and development of novel oncology therapeutics, devices, treatment-oriented information technology products, diagnostics, or tools. The objective of the SEED Award program is to start with an interesting technology and to progress it toward a commercially viable business opportunity, i.e., make it more attractive to private funding agents.

Award:  Up to $3 million over three years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas Diagnostic and Devices Company Awards

Revised: 10/11/2022

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of diagnostic tests and devices to treat, detect, diagnose, monitor, and assist in the treatment of cancer. The applicant should be working toward submitting an Investigational Device Exemption (IDE) or a 501(k) or Premarketing Approval (PMA) and is typically within one year from filing an IDE (or later stage work.)

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas New Technologies Company Awards

Revised: 10/11/2022

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of new and emerging technologies for the detection, diagnosis, prognosis, monitoring, or treatment of cancer. CPRIT created this RFA to fund new and emerging technology projects that do not easily fit into any of the three other CPRIT Product Development Research RFAs. Proposals may include, but are not limited to, bioinformatics, artificial intelligence, production of radionuclides or their precursors, manufacture of cell-based therapies, processes to improve the quality of the samples used for cancer research or clinical care, and biomanufacturing of therapeutics.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Texas Therapeutics Company Awards

Revised: 10/11/2022

Instructions for Applicants

Program Product Development Research
RFA Status Open
Description

Funding available to Texas-based companies and companies willing to relocate to Texas that will support the ongoing research and development of innovative therapeutics with a significant impact on the treatment of cancer.  The applicant is typically within one year from filing an IND/IDE or already in Phase 1.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release August 24, 2022
Application Receipt August 24, 2022 - May 01, 2023
Application Review August 2022 - July 2023
Award Notification Continuous

Recruitment of First-Time, Tenure-Track Faculty Members

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Supports very promising emerging investigators, pursuing their first faculty appointment in Texas, who have the ability to make outstanding contributions to the field of cancer research.

Award: Up to $2 million over a  period of five years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release June 21, 2022
Application Receipt June 21, 2022 - April 21, 2023
Application Review September 2022 - July 2023
Award Notification Continuous

Recruitment of Established Investigators

Instructions for Applicants

Program Academic Research
RFA Status Open
Description

Recruits outstanding senior research faculty with distinguished professional careers and established cancer research programs to academic institutions in Texas.

Award: Up to $6 million over a period of five years.

Review Cycle Fiscal Year 2023 - Cycle 1
RFA Release June 21, 2022
Application Receipt June 21, 2022 - April 21, 2023
Application Review September 2022 - July 2023
Award Notification Continuous